Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

321Catalyst Ventures

Profile, fund size and leaders

Parent Mitsui ChemicalsHQ San Jose, United StatesFounded 2025

321Catalyst Ventures is the corporate venture arm of Mitsui Chemicals, a chemicals and materials company. It was founded in 2025 and is based in San Jose, United States. It invests from seed to growth. Sectors it names: healthcare and digital health, mobility and automotive, enterprise software, climate and energy.

Fund sizeS1
USD 60M

Every figure links to its source

Snapshot

Investment stage: Seed to Growth
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Growth
SectorsHealthcare and digital health, Mobility and automotive, Enterprise software, Climate and energy, Biotech and life sciences
GeographyGlobal
OfficesSan Jose, United States

Sources: S1 Mitsui Chemicals: launch of 321Catalyst fund and 321Catalyst Ventures (26 May 2025).

Graphic 1 of 2

Investment stage: Seed to Growth

Sources: S1 Mitsui Chemicals: launch of 321Catalyst fund and 321Catalyst Ventures (26 May 2025).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeUSD 60MFund sizeStated by the firm or its parentS1

Sources: S1 Mitsui Chemicals: launch of 321Catalyst fund and 321Catalyst Ventures (26 May 2025).

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 Mitsui Chemicals: launch of 321Catalyst fund and 321Catalyst Ventures (26 May 2025).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
San Jose, United States
Offices
  • San Jose, United States

Investment regionsS1

LeadersS1S4

321Catalyst Ventures on LinkedIn

Key facts

FactValueStatusSource
Parent companyMitsui Chemicals (TSE: 4183)Single sourceS1
Parent industryChemicals and materialsSingle sourceS1
Founded2025Single sourceS1
HeadquartersSan Jose, United StatesSingle sourceS1
StatusActiveSingle sourceS2
Capital sourceParent company onlySingle sourceS1
Headline sizeUSD 60M (Fund size)Single sourceS1
StagesSeed, Series A, Series B, Series C+, GrowthSingle sourceS1

About Mitsui Chemicals

ItemDetailSource
Listed asTSE: 4183S1
HeadquartersJapanS1

Fund vehicles

VehicleSizeYearSource
321Catalyst LPUSD 60M2025S1
321FORCENot published2022S1

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2026-08-04Materia BioworksNot statedNot statedNoS2
2026-07-08TurtleTreeNot statedNot statedNoS3

History

  1. Mitsui Chemicals launched its first CVC fund 321FORCE with Global BrainS1
  2. 321Catalyst Ventures, Inc. established in April; 321Catalyst fund (USD 60 million) launched in MayS1
  3. Minority investment in Materia Bioworks announced 4 August 2026S2

Portfolio

Portfolio companies named in public sources: TurtleTree, Materia Bioworks.S3

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Mitsui Chemicals: launch of 321Catalyst fund and 321Catalyst Ventures (26 May 2025)Firm
  2. S2Mitsui Chemicals: investment in Materia Bioworks (4 Aug 2026)Firm
  3. S3Tridge/AgFunderNews: TurtleTree and Novonesis partnership with 321Catalyst VenturesPress
  4. S4Miho Tsukamoto LinkedIn profile (Vice President, 321Catalyst Ventures)Firm
  5. S5321Catalyst Ventures LinkedIn company pageFirm

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by 321Catalyst Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.